REPORT ID 6133

Global Hereceptin Biosimilar Market Research Report 2017

Publish Date
25-Dec-17
Pages
107
Format
Electronic (PDF)

In this report, the global Hereceptin Biosimilar market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Hereceptin Biosimilar in these regions, from 2012 to 2022 (forecast), covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
Global Hereceptin Biosimilar market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
    Mylan N.V.
    AryoGen Biopharma
    Genor Biopharma
    Celltrion Inc.
    Amgen Inc.
    Mabion S.A.
    The Instituto Vital Brazil
    F. Hoffmann-La Roche AG
    Biocon
    Gedeon Richter Plc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Tablet
    Capsule
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Pharmaceuticals
    Healthcare
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Hereceptin Biosimilar Market Research Report 2017
1 Hereceptin Biosimilar Market Overview
    1.1 Product Overview and Scope of Hereceptin Biosimilar
    1.2 Hereceptin Biosimilar Segment by Type (Product Category)
        1.2.1 Global Hereceptin Biosimilar Production and CAGR (%) Comparison by Type (Product Category)(2012-2022)
        1.2.2 Global Hereceptin Biosimilar Production Market Share by Type (Product Category) in 2016
        1.2.3 Tablet
        1.2.4 Capsule
    1.3 Global Hereceptin Biosimilar Segment by Application
        1.3.1 Hereceptin Biosimilar Consumption (Sales) Comparison by Application (2012-2022)
        1.3.2 Pharmaceuticals
        1.3.3 Healthcare
        1.3.4 Others
    1.4 Global Hereceptin Biosimilar Market by Region (2012-2022)
        1.4.1 Global Hereceptin Biosimilar Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
        1.4.2 North America Status and Prospect (2012-2022)
        1.4.3 Europe Status and Prospect (2012-2022)
        1.4.4 China Status and Prospect (2012-2022)
        1.4.5 Japan Status and Prospect (2012-2022)
        1.4.6 Southeast Asia Status and Prospect (2012-2022)
        1.4.7 India Status and Prospect (2012-2022)
    1.5 Global Market Size (Value) of Hereceptin Biosimilar (2012-2022)
        1.5.1 Global Hereceptin Biosimilar Revenue Status and Outlook (2012-2022)
        1.5.2 Global Hereceptin Biosimilar Capacity, Production Status and Outlook (2012-2022)

2 Global Hereceptin Biosimilar Market Competition by Manufacturers
    2.1 Global Hereceptin Biosimilar Capacity, Production and Share by Manufacturers (2012-2017)
        2.1.1 Global Hereceptin Biosimilar Capacity and Share by Manufacturers (2012-2017)
        2.1.2 Global Hereceptin Biosimilar Production and Share by Manufacturers (2012-2017)
    2.2 Global Hereceptin Biosimilar Revenue and Share by Manufacturers (2012-2017)
    2.3 Global Hereceptin Biosimilar Average Price by Manufacturers (2012-2017)
    2.4 Manufacturers Hereceptin Biosimilar Manufacturing Base Distribution, Sales Area and Product Type
    2.5 Hereceptin Biosimilar Market Competitive Situation and Trends
        2.5.1 Hereceptin Biosimilar Market Concentration Rate
        2.5.2 Hereceptin Biosimilar Market Share of Top 3 and Top 5 Manufacturers
        2.5.3 Mergers & Acquisitions, Expansion

3 Global Hereceptin Biosimilar Capacity, Production, Revenue (Value) by Region (2012-2017)
    3.1 Global Hereceptin Biosimilar Capacity and Market Share by Region (2012-2017)
    3.2 Global Hereceptin Biosimilar Production and Market Share by Region (2012-2017)
    3.3 Global Hereceptin Biosimilar Revenue (Value) and Market Share by Region (2012-2017)
    3.4 Global Hereceptin Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.5 North America Hereceptin Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.6 Europe Hereceptin Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.7 China Hereceptin Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.8 Japan Hereceptin Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.9 Southeast Asia Hereceptin Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
    3.10 India Hereceptin Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Hereceptin Biosimilar Supply (Production), Consumption, Export, Import by Region (2012-2017)
    4.1 Global Hereceptin Biosimilar Consumption by Region (2012-2017)
    4.2 North America Hereceptin Biosimilar Production, Consumption, Export, Import (2012-2017)
    4.3 Europe Hereceptin Biosimilar Production, Consumption, Export, Import (2012-2017)
    4.4 China Hereceptin Biosimilar Production, Consumption, Export, Import (2012-2017)
    4.5 Japan Hereceptin Biosimilar Production, Consumption, Export, Import (2012-2017)
    4.6 Southeast Asia Hereceptin Biosimilar Production, Consumption, Export, Import (2012-2017)
    4.7 India Hereceptin Biosimilar Production, Consumption, Export, Import (2012-2017)

5 Global Hereceptin Biosimilar Production, Revenue (Value), Price Trend by Type
    5.1 Global Hereceptin Biosimilar Production and Market Share by Type (2012-2017)
    5.2 Global Hereceptin Biosimilar Revenue and Market Share by Type (2012-2017)
    5.3 Global Hereceptin Biosimilar Price by Type (2012-2017)
    5.4 Global Hereceptin Biosimilar Production Growth by Type (2012-2017)

6 Global Hereceptin Biosimilar Market Analysis by Application
    6.1 Global Hereceptin Biosimilar Consumption and Market Share by Application (2012-2017)
    6.2 Global Hereceptin Biosimilar Consumption Growth Rate by Application (2012-2017)
    6.3 Market Drivers and Opportunities
        6.3.1 Potential Applications
        6.3.2 Emerging Markets/Countries

7 Global Hereceptin Biosimilar Manufacturers Profiles/Analysis
    7.1 Mylan N.V.
        7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.1.2 Hereceptin Biosimilar Product Category, Application and Specification
            7.1.2.1 Product A
            7.1.2.2 Product B
        7.1.3 Mylan N.V. Hereceptin Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.1.4 Main Business/Business Overview
    7.2 AryoGen Biopharma
        7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.2.2 Hereceptin Biosimilar Product Category, Application and Specification
            7.2.2.1 Product A
            7.2.2.2 Product B
        7.2.3 AryoGen Biopharma Hereceptin Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.2.4 Main Business/Business Overview
    7.3 Genor Biopharma
        7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.3.2 Hereceptin Biosimilar Product Category, Application and Specification
            7.3.2.1 Product A
            7.3.2.2 Product B
        7.3.3 Genor Biopharma Hereceptin Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.3.4 Main Business/Business Overview
    7.4 Celltrion Inc.
        7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.4.2 Hereceptin Biosimilar Product Category, Application and Specification
            7.4.2.1 Product A
            7.4.2.2 Product B
        7.4.3 Celltrion Inc. Hereceptin Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.4.4 Main Business/Business Overview
    7.5 Amgen Inc.
        7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.5.2 Hereceptin Biosimilar Product Category, Application and Specification
            7.5.2.1 Product A
            7.5.2.2 Product B
        7.5.3 Amgen Inc. Hereceptin Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.5.4 Main Business/Business Overview
    7.6 Mabion S.A.
        7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.6.2 Hereceptin Biosimilar Product Category, Application and Specification
            7.6.2.1 Product A
            7.6.2.2 Product B
        7.6.3 Mabion S.A. Hereceptin Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.6.4 Main Business/Business Overview
    7.7 The Instituto Vital Brazil
        7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.7.2 Hereceptin Biosimilar Product Category, Application and Specification
            7.7.2.1 Product A
            7.7.2.2 Product B
        7.7.3 The Instituto Vital Brazil Hereceptin Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.7.4 Main Business/Business Overview
    7.8 F. Hoffmann-La Roche AG
        7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.8.2 Hereceptin Biosimilar Product Category, Application and Specification
            7.8.2.1 Product A
            7.8.2.2 Product B
        7.8.3 F. Hoffmann-La Roche AG Hereceptin Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.8.4 Main Business/Business Overview
    7.9 Biocon
        7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.9.2 Hereceptin Biosimilar Product Category, Application and Specification
            7.9.2.1 Product A
            7.9.2.2 Product B
        7.9.3 Biocon Hereceptin Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.9.4 Main Business/Business Overview
    7.10 Gedeon Richter Plc
        7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
        7.10.2 Hereceptin Biosimilar Product Category, Application and Specification
            7.10.2.1 Product A
            7.10.2.2 Product B
        7.10.3 Gedeon Richter Plc Hereceptin Biosimilar Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
        7.10.4 Main Business/Business Overview

8 Hereceptin Biosimilar Manufacturing Cost Analysis
    8.1 Hereceptin Biosimilar Key Raw Materials Analysis
       8.1.1 Key Raw Materials
       8.1.2 Price Trend of Key Raw Materials
       8.1.3 Key Suppliers of Raw Materials
       8.1.4 Market Concentration Rate of Raw Materials
    8.2 Proportion of Manufacturing Cost Structure
       8.2.1 Raw Materials
       8.2.2 Labor Cost
       8.2.3 Manufacturing Expenses
    8.3 Manufacturing Process Analysis of Hereceptin Biosimilar

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
    9.1 Hereceptin Biosimilar Industrial Chain Analysis
    9.2 Upstream Raw Materials Sourcing
    9.3 Raw Materials Sources of Hereceptin Biosimilar Major Manufacturers in 2015
    9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
        10.1.1 Direct Marketing
        10.1.2 Indirect Marketing
        10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
        10.2.1 Pricing Strategy
        10.2.2 Brand Strategy
        10.2.3 Target Client
    10.3 Distributors/Traders List

11 Market Effect Factors Analysis
    11.1 Technology Progress/Risk
        11.1.1 Substitutes Threat
        11.1.2 Technology Progress in Related Industry
    11.2 Consumer Needs/Customer Preference Change
    11.3 Economic/Political Environmental Change

12 Global Hereceptin Biosimilar Market Forecast (2017-2022)
    12.1 Global Hereceptin Biosimilar Capacity, Production, Revenue Forecast (2017-2022)
        12.1.1 Global Hereceptin Biosimilar Capacity, Production and Growth Rate Forecast (2017-2022)
        12.1.2 Global Hereceptin Biosimilar Revenue and Growth Rate Forecast (2017-2022)
        12.1.3 Global Hereceptin Biosimilar Price and Trend Forecast (2017-2022)
    12.2 Global Hereceptin Biosimilar Production, Consumption , Import and Export Forecast by Region (2017-2022)
        12.2.1 North America Hereceptin Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.2 Europe Hereceptin Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.3 China Hereceptin Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.4 Japan Hereceptin Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.5 Southeast Asia Hereceptin Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
        12.2.6 India Hereceptin Biosimilar Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
    12.3 Global Hereceptin Biosimilar Production, Revenue and Price Forecast by Type (2017-2022)
    12.4 Global Hereceptin Biosimilar Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology/Research Approach
        14.1.1 Research Programs/Design
        14.1.2 Market Size Estimation
        14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
        14.2.1 Secondary Sources
        14.2.2 Primary Sources
    14.3 Disclaimer